The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers (BBMs).

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

Obesity shaves two to four years off the average lifespan, while being very obese can shorten your lifespan by 8 to 10 years, according to a new analysis of 57 studies including nearly 900,000 people.

Mike DeWine and others in his orbit indicate that the governor will spend his final year in office working to burnish his ...

Was that you I spotted at that New Year’s Day group class at my local YMCA? If not, don’t worry. It’s not too late. The start ...

People older than 65 represent prime targets for weight loss medications. The prevalence of obesity hovers around 40% in ...

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

Barzilay’s analysis of more than 10,500 children across 21 United States sites found that those who received phones at age 12 ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...

Americans in five states who get government help paying for groceries will see new limits starting Thursday on soda, candy ...